June Neurotech News Summary
North America is now four months into the pandemic. But the world of neurotechnology keeps moving. These developments could have or will have an impact on people living with neurological conditions. Let’s take a look at what made headlines over the month of June 2020.
These headlines address technical advancements, changes in access and expanding applications of current technologies.
The brain sensing revolution continues. Medtronic receives FDA approval for its Percept deep brain stimulation system with BrainSense technology. It has the ability to both sense brain signals and stimulation for those living with Parkinson’s disease.
Epineuron Technologies received FDA Breakthrough device status for their regeneration device for permanent nerve damage.
Myant partners with Canadian expert for denistry PPE innovation during COVID-19.
Fourier Intelligence acquires a China-based rehabilitation service provider to expand distribution of their exoskeleton for people living with paralysis.
MyndTec is partnering with Maness Veteran Medical to better serve U.S. veterans living with spinal cord injury or who are stroke survivors.
Endonovo Therapeutics, Inc. expanded access to their Softpulse device in Taiwan for the treatment of chronic pain.
Neuspera Medical completes the first implant of their minimally invasive, neuromodulation device in a two-stage pivotal clinical trial for the treatment of urinary urgency incontinence.
GTX medical gains FDA Breakthrough status for their TESS device for the recovery of function due to spinal cord injury.
Nearly 25% of U.S. adults have chronic knee pain. NeuroMetrix, Inc. announced their launch to help shrink that number by using the Quell device.
BioWave Corporation is hopping on the opportunity with Rocco Mediate to promote their peripheral nerve stimulation device for pain relief.
Neofect introduced their new app companion for a home-based rehabilitation device to restore arm & hand function for stroke survivors.
NeuroOne Medical Technologies is translating thin-film devices for the next generation of brain interfaces. They welcomed Camilo Andres Diaz-Botia to the team.
Akili announced FDA clearance of the EndeavorRx device for children living with ADHD. It is the first prescription treatment delivered through a video game.
Myomo, Inc. is now offering online screenings through telehealth for their upper extremity wearable robotics. Helpful for people living with stroke, brain injury, multiple sclerosis or spinal cord injury.
IHMC and Myolyn announced the breakthrough new exoskeleton, Quix, designed with the end-user in mind for people living with lower limb paralysis.
Mainstay Medical announced FDA approval of their ReActiv8 neurostimulation device for the treatment of chronic lower back pain.
ReWalk Robotics announced results from their multi-center trial for the soft exosuit used for rehabilitation after a stroke.
NeuroSigma’s Spanish team released the results of their randomized controlled trial of eTNS for drug resistant epilepsy.
Synchron received a grant of $1.5 million to expand their clinical trial of the Stentrode, a new generation brain interface designed to be used by people living with paralysis.
Dreem announced that their headband can be used as a home-based sleep analysis tool for people living with sleep disorders. A peer-reviewed study was just published.
Developing A.I. to screen people with the risk of eye disease, heart disease or stroke. Australia’s MRFF is investing $19 million in this technology.
June was Alzheimer’s Disease and PTSD awareness month.
Neurotech Network offers a feature of developments and the latest research in neurotech for Alzheimer’s disease or Dementia. There is also a link to our new resource page on this subject. Read the feature.
We also featured neurotechnology for Post-Traumatic Stress Disorder during the June awareness month. Check out our latest quick read on the feature and new resources page.
Free upcoming, virtual events not to miss:
Neuroprosthetics 2020 Virtual Summer School will be July 20–23. It’s free to register and attend but space is limited. Learn about rehabilitation technology, A.I. applications, neural interfaces and more.
MDIC, the Medical Device Innovation Consortium, transformed their annual meeting into a series of virtual sessions from June 18-September 24. Learn about advances in regulatory & clinical science and advances in end-user (patient) engagement in medical device development. All video archives are available too.
To follow our briefs throughout the month, follow us at Twitter or LinkedIn. Check out our resource directory on our website to find neurotechnologies for specific conditions.
The content for this article was provided by Neurotech Network. Help us support these free resources with a donation.
